KORU Medical Systems, Inc.

NASDAQ:KRMD

Medical - Instruments & Supplies

Healthcare
$3.45 +1.55%

+$0.06 today

Market cap
$149.64M
Beta
0.42
P/E (TTM)
-80.2
EPS (TTM)
-$0.05
52W Low $2.91High $6.61

Volume 0.19M

Average 0.13M

KRMD Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

KORU Medical Systems, Inc.NASDAQ: KRMD

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow declines year over year

Q1 FY2026 investing cash flow of $89.89K (cash outflow) fell 79.9% year over year, behind the -64.0% change in trailing-twelve-month investing cash flow. Sequentially, it fell 78.7% from the prior quarter. Over 3 fiscal years it compounded at -30.3% a year.

Context

  • Investing cash flow amounted to 2.3% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Investing cash flow grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -79.9% toward the trailing-twelve-month pace of -64.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$89.89K-78.7% QoQ
Last fiscal yearDec 2025
-$949.79K-28.8% YoY
LTMMar 2026
-$592.84K-64.0% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-79.9%——
1 year-28.8%——
3-year CAGR-30.3%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(949.79K) USD
Year-over-year change
+28.8%

Investing Cash Flow vs competitors

How KRMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -64.0% is the 4th highest of 8, against a peer median of -65.2%.
  • Investing cash flow amounts to 1.4% of revenue for KRMD, versus a peer median of 3.8%.
KRMD Competitors
Investing Cash Flow for KRMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NYXHNyxoah S.A.LTM Mar 2026€24.61M EUR+218.1%—150.8%
MXCTMaxCyte, Inc.LTM Mar 2026$19.06M USD-38.2%—59.0%
PREPrenetics Global LimitedLTM Mar 2026$13.63M USD—-8.1%12.0%
OSUROraSure Technologies, Inc.LTM Mar 2026$8.09M USD-202.8%—7.2%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$5.39M USD-65.2%-16.1%3.8%
STIMNeuronetics, Inc.LTM Mar 2026$753K USD-72.1%—0.5%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$592.84K USD-64.0%-30.3%1.4%
UTMDUtah Medical Products, Inc.LTM Mar 2026$317K USD-20.2%-23.2%0.8%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$265K USD-73.3%-22.3%0.6%
PROFProfound Medical Corp.LTM Mar 2026$246.24K USD——1.3%
Peer median (excluding KRMD) —-65.2%-19.2%3.8%

Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(4.56M)(8.66M)(13.74M)(6.07M)(2.64M)
Depreciation & Amortization463.13K587.14K870.39K888.47K810.5K
Deferred Income Tax(1.82M)(2.03M)3.97M00
Stock-Based Compensation2.71M3.08M2.77M2.62M2.71M
Change in Working Capital(1.11M)1.4M1.2M1.97M(319.17K)
Accounts Receivables(1.74M)(220.17K)457.18K(1.68M)(489.2K)
Inventory723.43K(298.53K)2.92M677.63K(874.46K)
Accounts Payables602.61K1.16M(1.42M)674.78K617.5K
Other Working Capital(698.28K)758.15K(760.19K)2.3M426.99K
Other Non-Cash Items(1.01K)212.55K37.82K259.55K(104.54K)
Operating Cash Flow(4.32M)(5.4M)(4.89M)(319.72K)462.41K
Capital Expenditures(375.23K)(2.8M)(814.6K)(1.3M)(932.52K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(19.99K)(40.51K)(31.65K)(35.62K)(17.27K)
Investing Cash Flow(366.17K)(2.8M)(814.6K)(1.33M)(949.79K)
Debt Repayment505.94K(127.14K)(218.87K)(107.96K)(379.98K)
Common Stock Issued2.2M406.62K00186.17K
Common Stock Repurchased000(97.38K)0
Dividends Paid00000
Other Financing Activities000(43.19K)(27.54K)
Financing Cash Flow2.71M279.49K(218.87K)(248.53K)(221.35K)
Effect of Forex Changes00000
Net Change in Cash(1.98M)(7.93M)(5.93M)(1.9M)(708.74K)
Free Cash Flow(4.69M)(8.21M)(5.71M)(1.62M)(470.11K)

KORU Medical Systems, Inc.

NASDAQ:KRMD

Intrinsic Alpha fair value

Locked

Current Price

$3.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.